NCT00561587View on ClinicalTrials.gov

Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

February 28, 2010

Conditions
Alcohol Relapse PreventionAlcoholismAlcohol DrinkingAlcohol ConsumptionAlcohol Abuse
Interventions
DRUG

Seroquel®

dosage form: oral, adjusted in the range of 25 to max. 300 mg /day

Trial Locations (1)

Unknown

Department of Psychiatry and Psychotherapy, University of Goettingen, Göttingen

All Listed Sponsors
lead

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

OTHER

NCT00561587 - Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study | Biotech Hunter | Biotech Hunter